Doctor profile · Federal record
Dr. Melvin Palalay, M.D.
Hematology & Oncology Physician (CMS: Hematology/Oncology) · Honolulu, HI
- NPI 1508833971
- Accepts Medicare
- MIPS 90.0 / 100 · 2023
- 35 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
1329 Lusitana St Ste 307
Honolulu, HI 968132435
(808) 524-6115
fax (808) 528-1711
Credentials & registration
- NPI registered
- March 2006 — 20 yrs on file
- Profile last updated
- July 18, 2019
- Year of graduation
- 1991 — 35 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State license (1)
- Hawaii #MD8905
- Medicaid
- HI #24930301
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1508833971. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
14,376
Distinct HCPCS
10
Medicare allowed
$415,916
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0897 |
Injection, denosumab, 1 mg | 3,559 | 23 | $23 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 1,446 | 459 | $130 | |
85025 |
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 1,180 | 343 | $8 | |
36415 |
Insertion of needle into vein for collection of blood sample | 1,154 | 342 | $5 | |
80048 |
Blood test, basic group of blood chemicals (calcium, total) | 1,034 | 306 | $8 | |
80076 |
Liver function blood test panel | 1,016 | 307 | $8 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 638 | 21 | $0 | |
84100 |
Phosphate level | 536 | 170 | $5 | |
84550 |
Uric acid level, blood | 534 | 172 | $4 | |
83735 |
Magnesium level | 532 | 167 | $7 |
In context: peer comparison
Among 12 peers in Honolulu Hematology & Oncology Physician, average services per provider: 222. This provider delivers 65× the peer median.Open Payments
Industry payments received
All-time total
$3,895
Transactions
106
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| AstraZeneca Pharmaceuticals Lp | 10 | $330.07 | |
| E.R. Squibb & Sons, L.L.C. | 18 | $304.88 | |
| Incyte Corporation | 13 | $294.12 | |
| Pfizer INC. | 6 | $216.50 | |
| Novartis Pharmaceuticals Corporation | 9 | $194.72 | |
| Abbvie INC. | 8 | $189.44 | |
| Janssen Biotech, INC. | 5 | $151.20 | |
| Jazz Pharmaceuticals INC. | 5 | $146.61 | |
| SpringWorks Therapeutics, INC. | 2 | $145.87 | |
| Lilly USA, LLC | 6 | $145.64 | |
| Daiichi Sankyo INC. | 7 | $140.81 | |
| Sobi, INC | 6 | $139.44 | |
| Stemline Therapeutics INC. | 3 | $116.49 | |
| Tempus Ai, INC | 5 | $115.17 | |
| Alexion Pharmaceuticals, INC. | 3 | $97.03 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
778
Patients
208
Total drug cost
$3,846,534
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Xgeva (Denosumab) | Brand | 126 | 23 | $392,141 |
| Anastrozole | Generic | 89 | 39 | $4,138 |
| Keytruda (Pembrolizumab) | Brand | 87 | 14 | $1,160,123 |
| Prolia (Denosumab) | Brand | 68 | 44 | $110,616 |
| Opdivo (Nivolumab) | Brand | 50 | 12 | $727,937 |
| Pantoprazole Sodium | Generic | 41 | 20 | $511 |
| Fosaprepitant Dimeglumine | Generic | 40 | 14 | $5,825 |
| Imfinzi (Durvalumab) | Brand | 39 | 0 | $481,738 |
| Darzalex Faspro (Daratumumab-Hyaluronidase-Fihj) | Brand | 37 | 0 | $387,713 |
| Tecentriq (Atezolizumab) | Brand | 37 | 0 | $397,310 |
Hospital affiliations
Frequently asked questions
What is Dr. Melvin Palalay's medical specialty?
Dr. Melvin Palalay practices Hematology & Oncology Physician in Honolulu, HI.
Where does Dr. Melvin Palalay practice?
Dr. Melvin Palalay practices at 1329 Lusitana St Ste 307, Honolulu, HI 968132435. Office phone: 8085246115.
What is Dr. Melvin Palalay's NPI?
Dr. Melvin Palalay's National Provider Identifier (NPI) is 1508833971, issued by NPPES.
Does Dr. Melvin Palalay accept Medicare assignment?
Yes. Dr. Melvin Palalay accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Melvin Palalay commonly perform?
Top Medicare-reported procedures in 2023: Injection, denosumab, 1 mg (HCPCS J0897); Established patient office or other outpatient visit (HCPCS 99214); Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS 85025). Source: CMS Medicare Physician & Other Practitioners file.